Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45results about How to "Stable preparation" patented technology

Toner preparation method and apparatus, and toner prepared thereby

A method of preparing a toner, including periodically dripping and discharging droplets of a toner constituent liquid comprising a resin and a colorant with a dripper comprising a thin film comprising plural nozzles configured to discharge the droplets, and an electromechanical converter configured to oscillate the thin film; and solidifying the droplets to form toner particles, wherein the nozzle has an aperture discharging the droplet, having a circular or an ellipsoidal cross-sectional shape and cross-sectional area smaller than a cross-sectional area of another aperture contacting the toner constituent liquid.
Owner:RICOH KK

Pigment dispersants and their use

ActiveUS20060185558A1Prevent flocculationExcellent spectral curve characteristicOrganic chemistryProjectorsAmmoniumSulfonic acid
A pigment dispersant contains the following component (a) alone or the following components (a) and (b) in combination: Component (a): a composite pigment formed of a diketopyrrolopyrrole pigment having a sulfonic group and another diketopyrrolopyrrole pigment having no sulfonic group, wherein the number of sulfonic group per molecule of the diketopyrrolopyrrole pigments in the composite pigment is from 0.05 to 0.5; and Component (b): a pigment other than the component (a), wherein the pigment has a sulfonic group or its metal salt, ammonium salt or amine salt. Also disclosed are a colored composition for color filters, a process for the fabrication of a color filter, the color filter fabricated by the process, an image display device including the color filter, and an information communication equipment including the image display device. These colored composition, process, color filter, image display device and information communication equipment all make either direct or indirect use of the pigment dispersant.
Owner:DAINICHISEIKA COLOR & CHEM MFG CO LTD

Process for producing film

The present invention provides a method making it possible to stably prepare a transparent film in which a cured layer having a micro protrusion and recess face structure is formed on the surface of a base material film. The preparation method of the present invention includes a step of sandwiching an active energy beam-curable resin composition including a photopolymerization initiator which can initiate polymerization of a polymerizable compound by absorbing light between the surface of a base material film which is supported by a supporting film, and a mold which has an inverse structure of the micro protrusion and recess face structure on the surface; a step of obtaining the transparent film supported by the supporting film by means of irradiating the active energy beam-curable resin composition with ultraviolet rays from the supporting film side; and a step of separating the transparent film and the mold.
Owner:MITSUBISHI RAYON CO LTD

Solid preparation for dialysis

InactiveUS20100120702A1Suppress productionSuppression of production of productBiocideCarbohydrate active ingredientsDecompositionOrganic acid
The present invention provides a glucose decomposition-suppressed solid preparation for dialysis among powdery or granular preparations for dialysis containing acetate-free solid organic acids as pH adjusting agents. The present invention provides the solid preparation for dialysis containing electrolytes, glucose and pH adjusting agents characterized in that solid organic acids containing reduced amount of microparticles are used, and more specifically, characterized in that solid organic acids whose 20 or less percent of particles are 250 μm or less in diameter, or solid organic acids whose 10 or less percent of particles are 150 μm or less in diameter, are used. Preferably, the solid organic acid contained therein is citric acid.
Owner:ADVANCED RENAL TECH

Composition and Method for a Producing Stable Amyloid Beta Oligomers of High Molecular Weight

The invention relates to a method for the preparation of a stable, soluble amyloid beta (Aβ) oligomer and composition thereof for use as an antigen for the generation of antibodies for the treatment of Alzheimer's disease and other conditions related to abnormal amyloid beta aggregation. The method which uses a pH in excess of 7.0 and high concentrations of Aβ, optionally includes the use of divalent anions or a helix-inducing solvent to form the oligomers. The stable, soluble Aβ oligomers produced by the method herein have a particle size of 10 to 100 nm in diameter, when measured by a dynamic light scattering technique, and a molecular weight of 100 to 500 kDa.
Owner:MERCK SHARP & DOHME CORP

Microcapsules, Method for Preparing Microcapsules, Fire-Extinguishing Agents, Materials, Coatings, and Articles Based Thereupon

The technical problem to be solved: (a) to increase stability of microcapsules having a core comprising a target lyophilic liquid with a low boiling point and which is immiscible with water, wherein said liquid is characterised in that it has the ability to hydrolyze and to form acidic products, said core being comprised in a spherical shell made of cured cross-linked polymeric material, which shell releases said target liquid when the surrounding environment has certain parameters leading to destruction of said shell; (b) to prevent the loss of the target liquid; and (c) to preserve microcapsule characteristics during long storage periods thereof. For this purpose the invention provides a method for producing microcapsules wherein a stabilising agent is added to the liquid to be encapsulated, which stabiliser suppresses the development of acidity during emulsification, coacervation and coalescence stages in a droplet of the liquid to be encapsulated and on the phase interface. AA 24 hours
Owner:LLC RUSINTECH

Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same

InactiveUS20090274748A1Excellent adhesive and cohesive strengthNot irritatedSurgical adhesivesPlastersMeth-Metal chelate
A nonaqueous pressure-sensitive adhesive for a medicinal tape preparation for percutaneous absorption comprising (a) a support, (b) a pressure-sensitive adhesive layer containing a drug and a nonaqueous pressure-sensitive adhesive and (c) a release film laminated in that order, and a medicinal tape preparation for percutaneous absorption comprising the adhesive. The nonaqueous pressure-sensitive adhesive may comprise a copolymer obtained by copolymerization of a (meth)acrylic monomer having an acetoacetyl group in the molecule and one or more monomers from among other (meth)acrylic monomers without acetoacetyl groups and copolymerizable vinyl monomers, in a nonaqueous solvent. Suitable (meth)acrylic monomers having an acetoacetyl group in the molecule are acetoacetoxyalkyl methacrylates, and especially 2-acetoacetoxyethyl methacrylate. The copolymer nonaqueous pressure-sensitive adhesive of the invention, comprising a (meth)acrylic monomer having an acetoacetyl group as a constituent monomer, is capable of containing large amounts of lipophilic oily substances in the pressure-sensitive adhesive layer, and during heat drying, the acetoacetyl groups undergo self-crosslinking to form a network structure as the solvent evaporates off, so that large amounts of oily substances such as the plasticizer can be included in the network structure. The pressure-sensitive adhesive of the invention uses no polyamine derivatives, isocyanate compounds, polyvalent metal chelate compounds, etc., as crosslinking agents, and therefore toxicity is not a concern and skin is not irritated. A medicinal tape preparation for percutaneous absorption of the invention has superior adhesive strength and cohesive strength, and is highly safe with low skin irritation. It also has excellent drug release and percutaneous absorption properties.
Owner:NIPRO PATCH

Methods for producing coating base papers and coated papers

The present invention provides methods for producing a base paper for coated printing paper and a coated paper by neutral papermaking using a roll and blade gap former type paper machine including a drainage mechanism based on a drainage blade immediately downstream of initial drainage via a forming roll, comprising adding a cationic polyacrylamide-based material having a weight-average molecular weight of 10,000,000 or more determined by intrinsic viscosity measurement as a retention aid to a stock to convert it into paper. According to the present invention, the retention, formation and internal bond strength of the stock can be improved. In the present invention, an anionic microparticle and / or a coagulant can also be used.
Owner:NIPPON PAPER IND CO LTD

Licorice polyphenol preparation

This invention provides a highly concentrated licorice polyphenol preparation with high bioavailability. Further, this invention is intended to maintain high transparency of a composition without deterioration of the indigenous properties of an aqueous substance, even when such composition is added thereto. Such licorice polyphenol preparation comprises a hydrophobic licorice extract comprising licorice polyphenol as a primary component, medium-chain fatty acid triglyceride, and polyoxyethylene sorbitan fatty acid ester, and the ratio of the total weight of the hydrophobic licorice extract and medium-chain fatty acid triglyceride to the weight of polyoxyethylene sorbitan fatty acid ester is between 1:1 and 1:10.
Owner:KANEKA CORP

Oxide film deposition method and oxide film deposition device

The present invention provides a method for forming an oxide film by which normal formation of an oxide film is always achieved without receiving an influence of a change in the atmosphere, a metal oxide film having a low resistance can be formed, and a high efficiency of film formation is obtained. In the present invention, a raw material solution containing an alkyl compound is formed into a mist and ejected to a substrate (100) in the atmosphere. Additionally, an oxidizing agent that exerts an oxidizing effect on the alkyl compound is supplied to the mist of the raw material solution. Through the above-described processes, an oxide film is formed on the substrate in the present invention.
Owner:TOSHIBA MITSUBISHI-ELECTRIC IND SYST CORP

Antibacterial imidazolium compound and antibacterial photocurable thiol-ene compositions comprising the same, and antibacterial polymer coatins prepared therefrom

An antibacterial imidazolium compound, a photocurable coating composition, and an antibacterial coating film includes a compound represented by Chemical Formula 1 shown below or derivatives thereof.In Chemical Formula 1, description of X−, R1 and, R2 is the same as in the detailed description of the invention. The antibacterial imidazolium compound has excellent antibiosis over various strains, and is included in a photocurable coating composition so as to provide an antibacterial coating film by a simple method. Also, in the antibacterial coating film, the antibacterial imidazolium compound is included as a monomer and chemically bonded to a polymer chain, and thus, antibacterial performance can be maintained for a long period of time.
Owner:KOREA INST OF SCI & TECH

Large coacervated capsules

The invention relates to a coacervated capsule comprising from 10 to 95% by weight of the capsule of a core comprising essentially a hydrophobic material, and from 90 to 5% by weight of the capsule of a coating layer comprising essentially a protein, and optionally a non-protein polymer, wherein the core further comprises from 0.01% to 30% by weight of the capsule of a cellulose ether derivative having an alkoxyl content from 35 to 60% and a degree of substitution of alkoxyl groups per anhydroglucose unit of from 2 to 3 and the viscosity of the core, measured at ambient temperature, is from about 100 mPa·s to 30000 mPa·s.
Owner:FIRMENICH SA

External plaster containing flurbiprofen

In a plaster for external use for transdermal absorption in which an adhesive layer is laminated on a plastic backing, the adhesive layer contains a styrene-isoprene-styrene block copolymer (SIS), a tackifying resin and a softener which are essential ingredients, and further contains flurbiprofen blended as an active ingredient. The present plaster for external use is a flurbiprofen containing plaster for external use enabling long-term stable release of contained flurbiprofen, and having excellent stability and very high drug releasing property.
Owner:TEIKOKU SEIYAKU KK TEIKOKU SEIYAKU CO LTD

Monolith catalyst for carbon dioxide reforming reaction, preparation method for same, and preparation method for synthesis gas using same

The present invention relates to a monolith catalyst for a carbon dioxide reforming reaction and to a preparation method for same, and more specifically the invention provides a preparation method for a monolith catalyst for a methane reforming reaction using carbon dioxide, the method comprising a step of mixing and impregnating a support in a metal precursor solution, coating a monolith substrate with the solution resulting from the mixing and impregnating, drying same and then calcining the monolith substrate coated with the solution resulting from the mixing and impregnating.
Owner:KOREA RES INST OF CHEM TECH

Solid preparation

A chewable tablet comprising a group which contains an acid-labile active ingredient and at least one basic substance selected from alkaline earth metal carbonate, metal oxide and metal hydroxide, and a group which does not contain an acid-labile active ingredient and contains at least one ingredient selected from alkaline earth metal carbonate, metal oxide and metal hydroxide, wherein said chewable tablet is capable of rapidly neutralizing gastric acid and is preferably not enteric-coated, is provided.
Owner:TAKEDA PHARMA CO LTD

Method for preparing soluble and active recombinant proteins using pdi as a fusion partner

The present invention relates to a method for producing a recombinant protein capable of increasing expression rate of a target protein and also improving solubility and folding of the expressed target protein using a modified protein disulfide isomerase (PDI) as a fusion partner, and an expression vector containing the modified PDI gene as a fusion partner. The method for preparing a recombinant protein using a modified PDI as a fusion partner according to the present invention may solve the problems concerning a low yield and solubility and folding that conventional fusion partners have, and be widely used for protein drug and industrial protein production.
Owner:PNP BIOPHARM

Budesonide formulation

InactiveUS20150202308A1Fast and reliable manufactureAvoid lostBiocideOrganic active ingredientsCyclodextrinBudesonide
The invention provides budesonide inhalation formulations containing cyclodextrins.
Owner:NEPHRON PHARM CORP

Method for preparing high purity isobutene using glycolether

Disclosed is a method of preparing isobutene in which high-purity isobutene is separated (prepared) from a C4 mixture by cracking glycol ether prepared from a C4 mixture (in particular, C4 raffinate-1) containing isobutene and a glycol. The method includes cracking glycol ether into isobutene and glycol at a temperature between 50° C. and 300° C. in the presence of a strongly acidic catalyst. The glycol ether may be prepared by reaction between a C4 mixture containing isobutene and glycol in the presence of an acid catalyst.
Owner:DL CHEM CO LTD

Supernatant of brown adipocytes, method for preparing same and utilization thereof

The present invention provides a composition having a metabolism-improving action, which comprises a supernatant of brown adipocytes or a purified product thereof. The present invention also provides a method of preparing the supernatant without using a culture solution comprising a high concentration of glucose. The present invention also provides a method of producing brown adipocytes using pluripotent stem cells, which are useful for preparing the supernatant of brown adipocytes. The present invention has succeeded in obtaining a supernatant having a metabolism-improving action from brown adipocytes. It was also possible to obtain the supernatant without using a culture solution comprising a high concentration of glucose. The present invention has also succeeded in producing brown adipocytes from pluripotent stem cells using a feeder-free culture system without adding a cytokine cocktail or the like. The brown adipocyte supernatant of the present invention is expected to be applied to the development of therapeutic agents and cosmetic products for glucose metabolism diseases.
Owner:ID PHARMA +1

Preparation equipment and preparation method of solid electrolyte membrane

The invention discloses preparation equipment and a preparation method of a solid electrolyte membrane. The preparation equipment of the solid electrolyte membrane comprises a plurality of rotary spray heads and a baking device, the rotary spray heads pressurize solid electrolyte and then spray the solid electrolyte on a base material, the baking device dries the base material sprayed with the solid electrolyte, and thus the solid electrolyte membrane is formed. The rotary spray heads adopt a rotary spraying process to pressurize solid electrolyte and then spray the solid electrolyte on the base material, and the solid electrolyte can be effectively, uniformly and controllably coated on the base material, so that the solid electrolyte membrane based on the base material is efficiently andstably prepared, and the process problem of large-scale preparation of the solid electrolyte membrane can be effectively solved based on the scheme; the base material plays a role in supporting a framework in the solid electrolyte membrane, so that the mechanical strength of the prepared solid electrolyte membrane is remarkably improved, the performance is excellent, and subsequent battery cell assembly is facilitated; and the membrane thickness of the solid electrolyte membrane is precisely controllable.
Owner:GAC AION NEW ENERGY AUTOMOBILE CO LTD

Epoxy resin composition for prepreg, prepreg, and multilayer printed circuit board

The problem to be solved by the invention is to provide an epoxy resin composition for a prepreg, which is used in the manufacture of a printed circuit board containing a multilayer printed circuit board, wherein the epoxy resin composition for a prepreg is characterized by containing as essential components, a phosphorus compound that has 1.8 or more and less than 3 on average of a phenolic hydroxyl group that is reactive to an epoxy resin in the molecule, and that has 0.8 or more on average of a phosphorus element; a bifunctional epoxy resin that has 1.8 or more and less than 2.6 on average of epoxy groups in the molecule; a multi-functional epoxy resin that contains 2.8 or more on average of epoxy groups in one molecule; a hardening agent; an inorganic filler; and a molybdenum compound, wherein the epoxy resin composition for a prepreg is obtained by blending a pre-reacted epoxy resin, which is obtained by reacting at least the phosphorus compound with the bifunctional epoxy resin and the multi-functional epoxy resin, or the bifunctional epoxy resin only in advance, the bifunctional epoxy resin or the multi-functional epoxy resin, the hardening agent, the inorganic filler, and the molybdenum compound, which is excellent in flame retardance, heat resistance, thermal stiffness, and excellent in hole position accuracy without the production of a harmful substance at the time of combustion, a prepreg using the epoxy resin composition for a prepreg, and a multilayer printed circuit board using the prepreg.
Owner:PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products